Yuki Imaoka

24PUBLICATIONS
35CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer geneticsCardiology (incl. cardiovascular diseases)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 04, 2026
Interleukin-37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence-Free Survival in Hepatocellular Carcinoma Patients.

|May 18, 2026
Serum Bile Acids Are Useful Indicators of Intrahepatic Recurrence After Initial Curative Hepatectomy for Hepatocellular Carcinoma.

|Sep 09, 2025
FIB-3 index as a novel age-independent predictor of liver fibrosis and prognosis in hepatocellular carcinoma patients undergoing hepatectomy.

Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi

|Apr 22, 2025
Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy.

Miho Akabane, Yuki Imaoka, Jun Kawashima

|Feb 05, 2025
Evaluating Predictors of Quality in Liver NK Cells Among Deceased Donors.

Yuki Imaoka, Masahiro Ohira, Toshihiro Nakayama

|Jan 06, 2025
The steatosis-associated fibrosis estimator score is a useful indicator of recurrence and survival after initial curative hepatectomy for hepatocellular carcinoma.

Tomoaki Bekki, Masahiro Ohira, Yuki Imaoka

Pageof 4

Frequent Collaborators

13 joint publications

Masahiro Ohira

10 joint publications

Hideki Ohdan

9 joint publications

Kazunari Sasaki

8 joint publications

Tsuyoshi Kobayashi